Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Molecular-Extrusion-Driven Halogen Homogenization for Efficient Perovskite-Silicon Tandem Solar Cells.

Angewandte Chemie (International ed. in English)·2026
Same author

Icariin alleviates ovariectomy-induced osteoporosis by promoting M2 macrophage polarization and suppressing osteoclast activation.

Cytokine·2026
Same author

An Integrated Study Based on UPLC-QTOF/MS Network Pharmacology and In Vivo Validation of the Anti-Obesity Effects of the 60% Ethanol-Eluted Fraction from <i>Rheum tanguticum</i>.

Plants (Basel, Switzerland)·2026
Same author

A Comprehensive Strategy for Characterizing Metabolites and Metabolic Profile in Rat Urine and Feces Following Oral Administration of Huachansu Tablets Based on UPLC-ESI-QTOF/MS<sup>E</sup>.

Biomedical chromatography : BMC·2026
Same author

Anterior Quadratus Lumborum Block with Liposomal Bupivacaine versus Ropivacaine for Postoperative Recovery in Laparoscopic Colorectal Surgery: A Randomized Controlled Trial.

Drug design, development and therapy·2026
Same author

Sponge-like porous Pd-SnO<sub>2</sub> with atomic-level doping for ultrafast and stable CO detection: Synergistic effects of lattice distortion and oxygen vacancies.

Talanta·2026

Related Experiment Video

Updated: Jul 10, 2026

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

A human cardiopulmonary model: extension to LV dysfunction.

Chuan Luo1, David L Ware, Joseph B Zwischenberger

  • 1Dept. of Electrical & Computer Engineering, Rice University, Houston, TX, USA.

Conference Proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference
|October 20, 2007
PubMed
Summary

We improved a cardiopulmonary model, validating it with new data and simulating heart conditions like diastolic dysfunction. This enhanced model aids in understanding complex cardiopulmonary diseases.

More Related Videos

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
10:08

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Published on: February 17, 2018

A Large Animal Model for Pulmonary Hypertension and Right Ventricular Failure: Left Pulmonary Artery Ligation and Progressive Main Pulmonary Artery Banding in Sheep
07:02

A Large Animal Model for Pulmonary Hypertension and Right Ventricular Failure: Left Pulmonary Artery Ligation and Progressive Main Pulmonary Artery Banding in Sheep

Published on: July 15, 2021

Related Experiment Videos

Last Updated: Jul 10, 2026

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
10:08

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Published on: February 17, 2018

A Large Animal Model for Pulmonary Hypertension and Right Ventricular Failure: Left Pulmonary Artery Ligation and Progressive Main Pulmonary Artery Banding in Sheep
07:02

A Large Animal Model for Pulmonary Hypertension and Right Ventricular Failure: Left Pulmonary Artery Ligation and Progressive Main Pulmonary Artery Banding in Sheep

Published on: July 15, 2021

Area of Science:

  • Cardiovascular Physiology
  • Computational Biology
  • Medical Simulation

Background:

  • Previous cardiopulmonary (CP) models require further validation and application.
  • Hemodynamic and echocardiographic data are crucial for CP model refinement.
  • Simulating cardiac dysfunction is essential for understanding disease progression.

Purpose of the Study:

  • To update and enhance a previously developed cardiopulmonary (CP) model.
  • To validate the updated CP model using comprehensive hemodynamic and echocardiographic data.
  • To demonstrate the model's utility by simulating left ventricular diastolic dysfunction (LVDD).

Main Methods:

  • Updating an existing computational cardiopulmonary model.
  • Incorporating additional hemodynamic and echocardiographic datasets for validation.
  • Modifying model parameters to simulate left ventricular diastolic dysfunction (LVDD).

Main Results:

  • The updated CP model shows improved validation against hemodynamic and echocardiographic data.
  • The model successfully simulates left ventricular diastolic dysfunction (LVDD) through parameter adjustment.
  • The enhanced model demonstrates robustness and accuracy in physiological representation.

Conclusions:

  • The refined cardiopulmonary model offers a more convincing representation of cardiorespiratory dynamics.
  • The model's ability to simulate LVDD highlights its potential for studying complex cardiac conditions.
  • This validated CP model is a valuable tool for characterizing diverse cardiopulmonary diseases, including heart failure and ARDS.